AwardTape · Defense awards · Curium US LLC
Curium US LLC: $1.6M in DoD and DHS awards
Curium US LLC holds 9 DoD and DHS prime awards with $1.6M obligated Oct 19, 2023 to Apr 16, 2026. Largest category: Drugs and biologicals at $1.5M; largest buyer: Department of the Army at $951K.
| Obligated FY2024+ | $1.6M |
|---|---|
| Awards | 9 |
| FY2024 | $550K |
| FY2025 | $650K |
| FY2026 to date | $428K |
| Lifetime obligated on these awards | $1.6M |
| Parent company (as reported) | Curium US Holdings LLC |
| First and latest action | Oct 19, 2023 · Apr 16, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Drugs and biologicals | $1.5M | 8 awards | 91% |
| 2 | Medical equipment and supplies | $150K | 1 awards | 9.2% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Department of the Army | $951K | 5 awards | 58% |
| 2 | Defense Health Agency | $677K | 4 awards | 42% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| W81K0025PA278 purchase order | $251K | Radiopharmaceuticals- wbamc. | Army | Drugs and biologicals | Jan 27, 2026 DoD 90d |
| W81K0024F0152 BPA call | $250K | Radiopharmaceuticals and supplies | Army | Drugs and biologicals | Nov 22, 2024 DoD 90d |
| HT001424F0106 BPA call | $250K | Radiopharmaceuticals, detect-net, kit in iii pentabromide for walter reed national medical center. | Defense Health Agency | Drugs and biologicals | Jun 6, 2024 DoD 90d |
| HT001425F0013 BPA call | $250K | Detectnet (copper cu-64 dotate) is a positron emission tomography imaging agent used for detecting neuroendocrine tumors. | Defense Health Agency | Drugs and biologicals | Apr 17, 2025 DoD 90d |
| W81K0023F0162 BPA call | $200K | Radiopharmaceticals and supples curium | Army | Drugs and biologicals | Oct 19, 2023 DoD 90d |
| HT001426PE101 purchase order | $177K | These are supplies which include detectnet 1mci/ml, which is a radioactive diagnostic agent used for positron emission tomography (pet) scans to locate somatostatin receptor-positive neuroendocrine tumors (nets). | Defense Health Agency | Drugs and biologicals | Apr 16, 2026 DoD 90d |
| W81K0024F0108 BPA call | $150K | Various radiopharmacueticals | Army | Medical equipment and supplies | Nov 6, 2024 DoD 90d |
| W81K0023F0131 BPA call | $100K | Various radiopharmacueticals | Army | Drugs and biologicals | Sep 4, 2024 DoD 90d |
| HT001420A0035 blanket purchase agreement | $0 | Master blanket purchase agreement for supplies and services | Defense Health Agency | Drugs and biologicals | Apr 15, 2025 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial